Korea S.E.
06:00:00 2024-04-25 pm EDT
5-day change
1st Jan Change
2,645
KRW
-0.75%
+0.57%
-3.82%
Apr. 23
Victex announced that it expects to receive KRW 4.999994272 billion in funding from AJU IB INVESTMENT Co., Ltd. and another investor
CI
Apr. 04
Coreline Soft Co., Ltd. announced that it has received KRW 18 billion in funding from AJU IB INVESTMENT Co., Ltd., BNH Investment LLC, Samsung Securities Co.,Ltd., NH Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd., K2 Investment Partners LLC
CI
PCL, Inc. agreed to acquire unknown minority stake in stake in mCureX Therapeutics, Inc. from OliX Pharmaceuticals, Inc, Samyang Holdings Corporation, AJU Good Growth Support Fund managed by Aju IB Investment Co., Ltd. and Kiwoom New Hero Fund I managed by Kiwoom Investment Co., Ltd. for KRW12.2 billion.
PCL, Inc. (KOSDAQ:A241820) agreed to acquire 40.76% stake in mCureX Therapeutics, Inc. from OliX Pharmaceuticals, Inc (KOSDAQ:A226950), Samyang Holdings Corporation (KOSE:A000070), AJU Good Growth Support Fund managed by Aju IB Investment Co., Ltd. (KOSDAQ:A027360) and Kiwoom New Hero Fund I managed by Kiwoom Investment Co., Ltd. for KRW12.2 billion on November 11, 2022. PCL, Inc. will acquire 0.54 million equity shares in mCureX Therapeutics, Inc. mCureX Therapeutics, Inc reported Total assets worth KRW 5.98 billion and net loss of KRW -1.1 billion in year ending December 31, 2021.
Victex announced that it expects to receive KRW 4.999994272 billion in funding from AJU IB INVESTMENT Co., Ltd. and another investor
Apr. 22
CI
Coreline Soft Co., Ltd. announced that it has received KRW 18 billion in funding from AJU IB INVESTMENT Co., Ltd., BNH Investment LLC, Samsung Securities Co.,Ltd., NH Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd., K2 Investment Partners LLC
Apr. 03
CI
Coreline Soft Co., Ltd. announced that it expects to receive KRW 18 billion in funding from AJU IB INVESTMENT Co., Ltd., BNH Investment LLC, Samsung Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd., K2 Investment Partners LLC and another investor
Apr. 01
CI
OliX Pharmaceuticals, Inc announced that it has received KRW 23.6 billion in funding from Kiwoom Investment Co., Ltd., AJU IB INVESTMENT Co., Ltd.
Dec. 14
CI
OliX Pharmaceuticals, Inc announced that it expects to receive KRW 23.6 billion in funding from Kiwoom Investment Co., Ltd., AJU IB INVESTMENT Co., Ltd.
Dec. 06
CI
Kristin Company Co., Ltd. announced that it has received KRW 7 billion in funding from Korea Development Bank, Investment Arm, TKG Ventures, BNK VENTURE CAPITAL Co., Ltd, AJU IB INVESTMENT Co., Ltd., Gyeongnam Venture Investment
Nov. 10
CI
MEZOO Co.,Ltd. announced that it has received KRW 18 billion in funding from a group of investors
Nov. 06
CI
Aju IB Investment Co., Ltd.(KOSDAQ:A027360) dropped from S&P Global BMI Index
23-09-18
CI
SPM Talos Co., Ltd. announced that it has received KRW 7.00000296 billion in funding from Aju IB Investment Co., Ltd.
23-04-27
CI
SPM Talos Co., Ltd. announced that it expects to receive KRW 7.00000296 billion in funding from Aju IB Investment Co., Ltd. and others
23-03-30
CI
M3SEN Co., Ltd. announced that it has received funding from AJU IB INVESTMENT Co., Ltd., KB Investment Co., Ltd, MAGNA Investment Co., Ltd. and another investor
23-01-15
CI
Ciena Corporation completed the acquisition of TiBiT Communications, Inc.
22-12-29
CI
WAY BRIDGE CO.,LTD. announced that it has received KRW 10 billion in funding from KB Investment Co., Ltd., JB Investment, NH Venture Investment, Aju IB Investment Co., Ltd., Leading Ace Capital Co.,Ltd.
22-12-21
CI
Lbox Co., Ltd. announced that it expects to receive funding from The Korea Development Bank, Daol Investment Co.,Ltd., Aju IB Investment Co., Ltd., SV Investment Corporation and other investors
22-12-19
CI
PCL, Inc. terminated the acquisition of 40.76% stake in mCureX Therapeutics, Inc. from OliX Pharmaceuticals, Inc, Samyang Holdings Corporation, AJU Good Growth Support Fund managed by Aju IB Investment Co., Ltd. and Kiwoom New Hero Fund I managed by Kiwoom Investment Co., Ltd.
22-12-11
CI
Onconic Therapeutics, Co., Ltd. announced that it has received KRW 26 billion in funding from a group of investors
22-12-08
CI
CORESTEM Inc. completed the acquisition of the remaining 47% stake in ChemOn Inc..
22-11-30
CI
JNPMEDI Inc. announced that it has received KRW 14 billion in funding from Pavilion Capital Fund Holdings Pte. Ltd, Kakao Ventures Corp., Murex Partners LLC, Aju IB Investment Co., Ltd., Gentium Partners, Inc.
22-11-21
CI
Ciena Corporation entered into a definitive agreement to acquire TiBiT Communications, Inc. for $210 million.
22-11-21
CI
Lifegoeson Company Corp. announced that it has received KRW 49.5 billion in funding from a group of investors
22-11-20
CI
PCL, Inc. agreed to acquire unknown minority stake in stake in mCureX Therapeutics, Inc. from OliX Pharmaceuticals, Inc, Samyang Holdings Corporation, AJU Good Growth Support Fund managed by Aju IB Investment Co., Ltd. and Kiwoom New Hero Fund I managed by Kiwoom Investment Co., Ltd. for KRW12.2 billion.
22-11-10
CI
CORESTEM Inc. agree to acquire remaining 47% stake in ChemOn Inc. for KRW 90 billion
22-08-15
CI
Twowhy Corp. announced that it has received funding from Aju IB Investment Co., Ltd., Enlight Ventures LLC
22-08-07
CI
IN Therapeutics Co.,Ltd. announced that it has received KRW 26 billion in funding from a group of investors
22-02-06
CI
Aju IB Investment Co., Ltd. and Highland Capital Partners LLC signed an agreement to acquire Sun Jin Precision Co. Ltd. from C&D International Investment Group Limited and Octus Investment for KRW 26.5 billion.
21-12-07
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
AJU IB INVESTMENT Co., Ltd. is a Korea-based company mainly engaged in the venture capital (VC) business and private equity (PE) business. The Company invests in small to medium enterprises (SMEs) and venture companies, provides initial public offering (IPO), merger and acquisitions (M&A), secondary support services, among others. The Company also operates private equity funds (PEF), provides mezzanine, buyout and corporate restructuring services.
More about the company
Stock Market Equities A027360 Stock
News Aju IB Investment Co., Ltd. PCL, Inc. agreed to acquire unknown minority stake in stake in mCureX Therapeutics, Inc. from OliX Pharmaceuticals, Inc, Samyang Holdings Corporation, AJU Good Growth Support Fund managed by Aju IB Investment Co., Ltd. and Kiwoom New Hero Fund I managed by Kiwoom Investment Co., Ltd. for KRW12.2 billion.
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
AJU IB INVESTMENT CO., LTD. 
